Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Metacrine, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +2 vs. Q2 2022
- Shares held
- 8.11M
- +1.98M (+32.4%) vs. Q2 2022
- Total value
- $3.93M
- +$870.0K (+28.4%) vs. Q2 2022
- New holders
- 6
- 5 more added
- Sold out
- 4
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 5 | $5.30M |
| Q4 2022 | 29 | $7.29M |
| Q3 2022 | 27 | $3.93M |
| Q2 2022 | 25 | $3.06M |
| Q1 2022 | 31 | $3.83M |
| Q4 2021 | 31 | $2.23M |
| Q3 2021 | 35 | $37.9M |
| Q2 2021 | 42 | $47.4M |
| Q1 2021 | 47 | $82.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Metacrine, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 235 | $0 | 0.00% | +42+21.8% | Added |
| Morgan Stanley | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 15 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | +3 | New |
| Edge Wealth Management LLC | 11,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Wedbush Securities Inc | 12,700 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 18,389 | $9.00K | 0.00% | +13,457+272.9% | Added |
| Northern Trust Corp | 26,163 | $13.0K | 0.00% | +9,524+57.2% | Added |
| Group One Trading, L.P. | 34,670 | $17.0K | 0.00% | −7,563−17.9% | Reduced |
| UBS Group AG | 42,651 | $21.0K | 0.00% | +32,078+303.4% | Added |
| Susquehanna International Group, LLP | 49,589 | $24.0K | 0.00% | +2,725+5.8% | Added |
| Two Sigma Advisers, LP | 62,500 | $30.0K | 0.00% | −25,400−28.9% | Reduced |
| State Street Corp | 72,186 | $35.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 76,235 | $36.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 100,444 | $48.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 136,606 | $66.0K | 0.00% | +136,606 | New |
| Vivo Capital, LLC | 146,426 | $71.0K | 0.01% | 00.0% | Unchanged |
| CSS LLC | 169,344 | $82.0K | 0.00% | +169,344 | New |
| Jane Street Group, LLC | 173,328 | $84.0K | 0.00% | +173,328 | New |
| Bank of New York Mellon Corp | 205,616 | $100.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 254,492 | $123.0K | 0.00% | −193,934−43.2% | Reduced |
| Tudor Investment Corp Et Al | 349,100 | $169.0K | 0.00% | +349,100 | New |
| Renaissance Technologies LLC | 579,536 | $281.0K | 0.00% | −9,304−1.6% | Reduced |
| Artal Group S.A. | 924,898 | $449.0K | 0.02% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,718,220 | $833.0K | 0.10% | +1,718,220 | New |
| ARCH Venture Management, LLC | 2,940,503 | $1.43M | 0.18% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −198,230−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −158,659−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −28,468−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −244−100.0% | Sold out |